Sandhoff Disease Latest Advances

Find the Latest Research About Sandhoff Disease

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 557 publications

Decoding the Hex-GM2-MGL2 axis in microglia-neuron crosstalk.

Decoding the Hex-GM2-MGL2 axis in microglia-neuron crosstalk.

Journal: Trends in pharmacological sciences
Published: October 07, 2025

3D bioprinted neural scaffolds: a transformative avenue for GM2 gangliosidosis therapy.

3D bioprinted neural scaffolds: a transformative avenue for GM2 gangliosidosis therapy.

Journal: Annals of medicine and surgery (2012)
Published: October 03, 2025

Bioprinting neural tissue to decode Sandhoff disease: promise and barriers.

Bioprinting neural tissue to decode Sandhoff disease: promise and barriers.

Journal: Annals of medicine and surgery (2012)
Published: October 01, 2025

Five-year analysis of efficacy and safety of a bidirectional AAV gene therapy in Tay-Sachs sheep.

Five-year analysis of efficacy and safety of a bidirectional AAV gene therapy in Tay-Sachs sheep.

Journal: The Journal of clinical investigation
Published: September 30, 2025

Similarities and Differences in the Late-Onset GM2 Gangliosidoses: Tay-Sachs and Sandhoff Diseases.

Similarities and Differences in the Late-Onset GM2 Gangliosidoses: Tay-Sachs and Sandhoff Diseases.

Journal: medRxiv : the preprint server for health sciences
Published: September 19, 2025

Myotonic Discharges in Infantile Sandhoff Disease.

Myotonic Discharges in Infantile Sandhoff Disease.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: May 21, 2025

Therapeutic Effects of Nizubaglustat in a Mouse Model of GM2 Gangliosidosis.

Therapeutic Effects of Nizubaglustat in a Mouse Model of GM2 Gangliosidosis.

Journal: Journal of inherited metabolic disease
Published: May 14, 2025

Advances in Diagnosis, Pathological Mechanisms, Clinical Impact, and Future Therapeutic Perspectives in Tay-Sachs Disease.

Advances in Diagnosis, Pathological Mechanisms, Clinical Impact, and Future Therapeutic Perspectives in Tay-Sachs Disease.

Journal: Neurology international
Published: May 04, 2025

Deep Learning Cerebellar Magnetic Resonance Imaging Segmentation in Late-Onset GM2 Gangliosidosis: Implications for Phenotype.

Deep Learning Cerebellar Magnetic Resonance Imaging Segmentation in Late-Onset GM2 Gangliosidosis: Implications for Phenotype.

Journal: medRxiv : the preprint server for health sciences
Published: April 29, 2025

Secondary accumulation of lyso-platelet activating factors in lysosomal storage diseases.

Secondary accumulation of lyso-platelet activating factors in lysosomal storage diseases.

Journal: Molecular genetics and metabolism
Published: March 17, 2025

Late-onset GM2 gangliosidosis: magnetic resonance imaging, diffusion tensor imaging, and correlational fiber tractography differentiate Tay-Sachs and Sandhoff diseases.

Late-onset GM2 gangliosidosis: magnetic resonance imaging, diffusion tensor imaging, and correlational fiber tractography differentiate Tay-Sachs and Sandhoff diseases.

Journal: Journal of neurology
Published: January 17, 2025

Tay-Sachs and Sandhoff Diseases: Diffusion tensor imaging and correlational fiber tractography findings differentiate late-onset GM2 Gangliosidosis.

Tay-Sachs and Sandhoff Diseases: Diffusion tensor imaging and correlational fiber tractography findings differentiate late-onset GM2 Gangliosidosis.

Journal: medRxiv : the preprint server for health sciences
Published: January 13, 2025
Showing 1-12 of 557

Last Updated: 02/24/2026